Amgen Aktie
| 384,22USD | 16,49USD | 4,48% |
WKN: 867900 / ISIN: US0311621009
Personal
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 24 200 | 25 200 | 26 700 | 28 000 | 0 |
| Umsatz pro Mitarbeiter in Mio. EUR | 1,07 | 1,04 | 1,05 | 1,19 | 0,00 |
Bilanz (in Mio. USD) - Aktiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 19 385 | 22 186 | 30 332 | 29 030 | 29 057 |
| Summe Anlagevermögen | 41 780 | 42 935 | 66 822 | 62 809 | 61 529 |
| Summe Aktiva | 61 165 | 65 121 | 97 154 | 91 839 | 90 586 |
Bilanz (in Mio. USD) - Passiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 54 465 | 61 460 | 90 922 | 85 962 | 81 928 |
| Summe Eigenkapital | 6 700 | 3 661 | 6 232 | 5 877 | 8 658 |
| Summe Passiva | 61 165 | 65 121 | 97 154 | 91 839 | 90 586 |
Adresse
| One Amgen Center Drive, 91320-1799 Thousand Oaks | |
| Telefon | +1 (805) 447-1000 |
| Internet | http://www.amgen.com |
Management
|
Amy E. Miles
Independent Director |
|
Brian J. Druker
Independent Director |
|
Charles M. Holley
Independent Director |
|
Darryl Sleep
Senior Vice President-Global Medical |
|
David M. Reese
Chief Technology Officer & Executive VP |
|
Derek Miller
Chief Human Resources Officer |
|
Ellen Jamison Kullman
Independent Director |
|
Esteban Santos
Executive Vice President-Operations |
|
Greg C. Garland
Independent Director |
|
Greg Portner
Senior VP-Global Government Affairs & Policy |
|
Howard Y. Chang
Chief Scientific Officer & SVP-Global Research |
|
Jackie Elbonne
Chief Quality Officer & Senior Vice President |
|
James E. Bradner
Executive VP-Research & Development |
|
Jean-Charles Soria
Senior VP-Research & Development |
|
Jonathan P. Graham
Secretary, Executive VP & General Counsel |
|
Justin Gary Claeys
VP, Head-Financial Planning & Analysis |
|
Kave Niksefat
Senior Vice President-Global Marketing & Access |
|
Linda H. Louie
Vice President-Finance |
|
Linda H. Louie
Chief Accounting Officer & Vice President-Finance |
|
Mark J. Taisey
Senior VP-Global Regulatory Affairs & Strategy |
|
Mary Earley Klotman
Independent Director |
|
Matthew C. Busch
Chief Accounting Officer & Vice President-Finance |
|
Michael V. Drake
Independent Director |
|
Murdo J. Gordon
EVP-Global Commercial Operations |
|
Nancy A. Grygiel
Chief Compliance Officer |
|
Omar Syed Ishrak
Independent Director |
|
Paul Burton
Chief Medical Officer & Senior Vice President |
|
Peter H. Griffith
Chief Financial Officer & Executive Vice President |
|
Rachna Khosla
Senior Vice President-Business Development |
|
Robert A. Bradway
Chairman, President & Chief Executive Officer |
|
Robert A. Eckert
Lead Independent Director |
|
Sam Guhan
Senior Vice President-Global Engineering |
|
Scott Skellenger
Chief Information Officer & Senior VP |
|
Susan Sweeney
Executive VP-Obesity & Related Conditions |
|
Tyler E. Jacks
Independent Director |
|
Wanda M. Austin
Independent Director |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.